Troels Jordansen, Executive Chairman of Keli Therapeutics, in Cell Therapy and Biotech Recession Talks

A Dose of Reality with Charles Spence

In this episode, I talked with Troels Jordansen, chairman at KELI Therapeutics, where he discusses the ongoing recession in the biotech industry. He shares insights from the Advanced Therapies Congress in Lisbon, highlighting investor optimism and the importance of smart hiring and team building in biotech companies.

Troels shares valuable lessons learned from past experiences, including the need for companies to secure sufficient funding and the significance of having the right people in key positions. The discussion also covers Troels' interest in the hair care market, highlighting its increasing connection with biotech.

Here's what you're in:

• What do people forget during the good times?
• Why this recession is not the worst?
• What are the big mistakes companies are still making?

Timestamps:

02:17 Introduction and Career Background

07:43 Biotech Recession and Insights from the Advanced Therapies Congress

12:46 Strategies on Reaching Out to Investors

18:13 The Challenges of Being in a Hiring Position

21:16 Finding the Right People for the Team

25:50 Lessons from Past and the Current State of the Biotech Inddustry

28:36 Exploring the Hair Care Market

About Troels

Troels Jordansen is the Executive Chairman at KELI Therapeutics, a stem cell and gene therapy company based in Lithuania, with nearly 30 years of experience in international healthcare of which about 25 years focusing on tissue engineering and cellular therapies. Though not a scientist, his commercial expertise has led him to roles in pioneering companies like Genzyme and Isotis, where he contributed to major innovations and IPOs. Troels has a marketing and management background earned from Copenhagen Business School and Aarhus Business College.

Connect with Troels

• LinkedIn: https://www.linkedin.com/in/troelsjordansen/
• Website: https://keli.eu/

About me

My name is Charles Spence and I lead Discera. After many years working in the life-science recruitment world, I decided to work for myself. Before doing recruitment I graduated with a biomedical degree, have worked in hospitals (including translation work in Seoul, South Korea), and also spent a year working in diabetes research in Stockholm. After doing research and travel, a career in business and science felt the most appropriate.

In 2023, I decided to launch his firm - Discera Search. A firm committed to solving the biggest talent needs of early clinical stage SME biotechs on the East Coast and DACH.

Connect with me:

• LinkedIn: https://www.linkedin.com/in/charles-spence-clinical/
• Website: https://www.discera-search.com/

Opinions and comments expressed by the guest do not represent the company and are fully their own.